Decoding Ovarian Tumors in Young Girls: A 25-Year Study
"Understanding the prevalence, types, and treatment approaches for ovarian tumors in children and adolescents in India."
Ovarian tumors in children and adolescent girls are rare, yet significant, gynecological malignancies. They account for a small percentage of childhood malignancies, making them an area of concern for both patients and healthcare providers. Understanding the characteristics of these tumors is crucial for early diagnosis and effective treatment.
Historically, ovarian cysts were considered infrequent in young girls due to their origin from mature follicles. However, this perception has evolved, necessitating a deeper understanding of the different types of ovarian tumors and their occurrence in the pediatric population. This article explores a retrospective study conducted over 25 years in a tertiary care hospital in India, aiming to shed light on the incidence and clinicopathological features of ovarian tumors in girls up to 20 years of age.
This research aims to provide clarity on the types of ovarian tumors affecting young girls, their clinical presentation, and effective management strategies. By understanding the specific characteristics of these tumors, healthcare professionals can improve diagnostic accuracy and treatment outcomes.
Current Burden and Pediatric Context
The CDC provides the latest federal data on ovarian cancer cases and deaths in the U.S. through its ovarian cancer statistics resources. Pediatric ovarian neoplasms account for about 1% of neoplasms in females younger than 17, according to a 2024 review. These tumors are usually benign, although malignant tumors can occur in the pediatric age group. U.S. cancer data can also be explored through CDC Data Visualizations and the National Cancer Institute's SEER statistics resources.
Diagnosis, Surgery, and Their Limits
Evaluation of pediatric and young adult ovarian masses considers clinical, pathological, and surgical characteristics, including malignancy risk, recurrence, and fertility outcomes. Cross-sectional imaging is considered reliable, but it is not always performed. The available review notes that laparoscopic tumourectomy is popular but is not recommended by the International Paediatric Surgical Oncology Society because tumor spillage remains a central concern. Transabdominal imaging is generally not considered compromised in children because of their smaller size, relatively lower abdominal fat, and the often larger size of ovarian tumors.
A Distinct Pediatric Tumor Spectrum
Foundational descriptions of childhood and adolescent ovarian tumors recognize a broad range of entities derived from germinative, stromal, and epithelial components. In children and adolescents, malignant tumors are predominantly of germinal origin, comprising 70% of cases in the cited Springer source. Epithelial tumors, which are most common in adults, account for approximately 15% of pediatric and adolescent cases and become more frequent in adolescents and young adults. More recent clinical reviews emphasize imaging, tumor markers, and fertility-sparing surgery when possible.
Key Findings: Types, Prevalence, and Malignancy
The study analyzed 112 cases of ovarian tumors in girls up to 20 years of age, revealing a mean age of 15.3 years at diagnosis. The most common presenting complaint was abdominal pain, highlighting the importance of considering ovarian masses in young girls presenting with this symptom. The study found a statistically significant correlation between the size of the tumor and its malignancy status, emphasizing the need for careful evaluation of larger masses.
- Mature Cystic Teratomas: Most common benign tumor (27.6%)
- Immature Teratomas: Most common malignant tumor (8%)
- Abdominal Pain: Most frequent presenting complaint (46.4%)
- Malignancy Rate: 34.8% of the studied cases were malignant.
Evidence-Based Pediatric Care
The National Cancer Institute's Childhood Ovarian Cancer Treatment PDQ is an evidence-based, expert-reviewed summary of pediatric ovarian cancer. It covers clinical presentation, risk factors, histology, molecular features, prognosis, and treatment. This scope reflects the need to integrate pathological and molecular information with clinical management when studying ovarian cancer in children.
Outcomes in Tertiary Care
A 2025 study examined pediatric patients with ovarian cancer and borderline masses presenting to a large tertiary pediatric hospital. Its focus was the patients' clinical characteristics, interventions, and outcomes. Because the study addresses a specific urban tertiary-hospital population, its findings describe that care setting rather than necessarily representing every child with an ovarian malignancy.
Pediatric Versus Adult Priorities
Ovarian cancer in children and adolescents is rare and presents diagnostic and management challenges distinct from adult disease. A recent overview emphasizes multidisciplinary care for this population. Pediatric treatment must balance appropriate surgical management with preservation of future reproductive capability. Preoperative estimation of malignant potential is therefore important when selecting an optimal surgical strategy.
Translating Findings into Improved Care
This research underscores the importance of maintaining a high index of suspicion for ovarian masses in young girls presenting with abdominal pain. Prompt investigations, such as ultrasound, are crucial for early detection and accurate diagnosis. By recognizing the varied presentations of ovarian tumors and understanding their prevalence, healthcare professionals can expedite the diagnostic process and initiate timely treatment.
Frozen Section and Surgical Decisions
Frozen section is used as an intraoperative aid when clinicians must determine the extent of surgical staging. A review specifically assessed concordance between intraoperative frozen-section results and final diagnoses in pediatric and adolescent patients with malignant ovarian germ cell tumors. The purpose is to guide surgical decisions while awaiting definitive pathology. Its usefulness therefore depends on how closely the intraoperative assessment matches the final diagnosis.
Fertility and Quality of Life
Future care for ovarian cancer in children and adolescents is framed around achieving oncological control while preserving future fertility and quality of life. A 2024 review aims to guide clinicians toward optimal care for this distinct patient population. This outlook places reproductive and long-term quality-of-life outcomes alongside cancer treatment when evaluating progress.
A Biology Different from Adult Disease
Pediatric ovarian cancers create challenges that differ substantially from those encountered in adults. Research on microRNAs and pediatric ovarian cancers reviews the spectrum of cancers found in girls and young women while focusing on the biology of these diseases. The distinct biology adds complexity to diagnosis and treatment and supports studying pediatric tumors as their own clinical group rather than simply applying adult assumptions.
Living Through Uncertainty
For a girl and her family, an ovarian mass can bring uncertainty about diagnosis, treatment, and long-term reproductive health. The available material supports viewing care as a balance between controlling disease and protecting future fertility and quality of life. Because no subsection-specific source was provided for this human-impact discussion, these points are presented broadly rather than as quantified outcomes.
The study highlights the effectiveness of surgical interventions, such as cystectomy and salpingo-oophorectomy, in managing ovarian tumors in young girls. The choice of treatment should be tailored to the individual patient, considering the tumor type, stage, and extent of the disease. A multidisciplinary approach, involving surgeons, oncologists, and pathologists, is essential for optimizing treatment outcomes and preserving fertility whenever possible.
While this study provides valuable insights into the spectrum of ovarian tumors in young girls in India, further research is needed to explore the long-term outcomes and quality of life of these patients. Additionally, studies are needed to identify potential risk factors and develop preventive strategies to reduce the incidence of ovarian tumors in this vulnerable population. By continuing to invest in research and innovation, we can improve the lives of young girls affected by ovarian tumors and ensure they receive the best possible care.